What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06746441 - Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers
Clinical Trial in Peshawar, Khyber Pakhtunkhwa
This randomized controlled clinical trial evaluates the effectiveness of psilocybin and psilocybin-assisted cognitive behavioral therapy (CBT) in the management of Major Depressive Disorder (MDD). The study aims to compare the effects of psilocybin-only therapy, CBT, and psilocybin-assisted CBT on depression symptoms, neurochemical markers, inflammatory markers, and neuroplasticity in individuals with MDD. Partici... Source record lists lead sponsor Khyber Medical University Peshawar and overall status Completed.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06746441
- Last Verified
- 2026-06-12
Location
Lady Reading Hospital, Pakistan, Peshawar, Khyber Pakhtunkhwa
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06746441; status Completed; sponsor Khyber Medical University Peshawar.
Source: https://clinicaltrials.gov/study/NCT06746441
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.